Zhejiang Hisoar Pharmaceutical Second Quarter 2024 Earnings: EPS: CN¥0.003 (vs CN¥0.013 loss in 2Q 2023)

Simply Wall St · 09/01 01:06

Zhejiang Hisoar Pharmaceutical (SZSE:002099) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥510.4m (down 9.2% from 2Q 2023).
  • Net income: CN¥5.51m (up from CN¥22.9m loss in 2Q 2023).
  • Profit margin: 1.1% (up from net loss in 2Q 2023).
  • EPS: CN¥0.003 (up from CN¥0.013 loss in 2Q 2023).
earnings-and-revenue-history
SZSE:002099 Earnings and Revenue History September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Zhejiang Hisoar Pharmaceutical shares are up 5.4% from a week ago.

Risk Analysis

Be aware that Zhejiang Hisoar Pharmaceutical is showing 1 warning sign in our investment analysis that you should know about...